The International Organization for the Study of Inflammatory Bowel Disease held a single-day meeting focused on challenges and opportunities in trial design. The meeting included 95 registrants and consisted of 2 plenary presentations and 3 breakout sessions. The overall goals of the meeting were to identify challenges that must be met in the design of clinical studies of new and established therapies for inflammatory bowel disease (IBD).
No takes yet. Share an insight, caveat, or question.
Dubinsky et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: